- Morgan Stanley recommended 10 stocks that they think will perform well as the US faces its next presidential election and as the world recovers from the coronavirus pandemic.
- Analysts recommended six pharmaceutical stocks — despite political rhetoric bashing drug prices.
- UnitedHealth Group is expected to do well regardless of whether President Donald Trump or former Vice President Joe Biden wins the election.
- For more stories like this, sign up here for Business Insider’s daily healthcare newsletter.
Two big questions are looming in the coming months: Who will win the US presidential election? And how quickly will the world will emerge from the coronavirus pandemic?
Republican President Donald Trump is campaigning for a second term against his Democratic opponent, Joe Biden. Aside from the coronavirus pandemic, among the biggest uncertainties for healthcare companies are the future of the Affordable Care Act — including whether lawmakers will move to expand government health
- Greenlight, the personal financial management app for kids and parents, has seen its user base double since the start of the year.
- With this growth, Greenlight is building an investing product, where kids can propose stock and ETF trades to their parents.
- “To build true wealth, you really need to learn how to invest,” Tim Sheehan, cofounder and CEO of Greenlight, told Business Insider. “So we want the kids to try to learn that as early as they can, and to do it in a supervised environment.”
- Greenlight is backed by investors including JPMorgan Chase, and Wells Fargo.
- Visit Business Insider’s homepage for more stories.
A personal finance app for kids that’s managed by their parents has doubled its user base in the first half of this year.
Greenlight, which currently offers debit cards and savings accounts, is eyeing more financial products to launch for its parent and child users
The U.S. dollar is slumping, but investors could still make some greenbacks off of a few key stocks.
FX strategists at Goldman Sachs predict the trade-weighted USD will weaken some 5.3% in the coming year, off of a roughly 4% slump from mid-May, strategists at the firm wrote in a note Friday.
To be sure, the dollar has taken a beating recently (the U.S. Dollar Index is down about 4% in the last month)—And there are those that are predicting the coronavirus crisis could topple its supremacy altogether. But despite the selloff, strategists at Goldman believe “the greenback remains overvalued by most metrics and offers poor fundamentals.”
Indeed, Morgan Stanley’s chief investment officer Lisa Shalett wrote in a Monday note that “we finally see the dollar bull dying, too, as the forces that created dollar scarcity—superior relative growth and yields, a shrinking current account deficit and more effective post-crisis policies—fade.”
In terms of market volatility, this year is definitely one for the books. 2020 saw market movements that would normally take decades, compressed into a single year. With unemployment rates at their highest and businesses facing the risk of bankruptcy, the economy hit some new lows this year. However, a period of downturn also presents a unique opportunity for investors to load up on growth stocks to buy at a discounted price.
Historically speaking, a bear market in the S&P 500 was always replaced by a bull market rally in the years before Covid-19.
While it’s hard to remain optimistic in uncertain times, investors need to take a long-term approach when investing in stocks. Some companies are likely to emerge from the pandemic as losers. Others will come out of this stronger than ever.
InvestorPlace – Stock Market News, Stock Advice & Trading Tips
Here are seven growth stocks that
Investors have been agonized by the coronavirus pandemic-triggered market sell offs. However, the benchmark indices touched a fresh high two days back, thanks to the positive sentiment surrounding the news of the U.S. government placing an initial vaccination order of 100 million doses to Pfizer and BioNTech.
Policymakers have left no stone unturned to provide an impetus to the market. The Fed slashed the benchmark interest rate to nearly zero and a quantitative easing program too was announced to increase money supply. President Trump signed economic relief packages to help small businesses, hospitals as well as to boost testing.
Now the big question is which investment strategy can you resort to right now? Some investors have managed to bridge the gap between value and growth with a hybrid strategy of investment called GARP (growth at a reasonable price). Their theory suggests that the principles of both value and growth strategies
Sometimes, the buying opportunities aren’t so obvious. It’s the job of Wall Street’s investment and research firms to clarify the situation – and Wedbush has been at the forefront of stock research for 65 years. The firm’s cadre of 52 analysts have more than 3,400 reviews on record – their collective finger is on the pulse of the stock market. And in recent weeks, they have pointed out three stocks that investors should consider buying.
We’ve used the TipRanks database to pull up the details on these stocks. They’re an eclectic bunch, covering a variety of business sectors, and Wedbush’s analysts see a far higher upside potential for each of them than Wall Street’s conventional wisdom would allow. Two of these stocks have been upgraded to Buy; one has been initiated at a Buy. Let’s find out why.
First on our list is one of the world’s most
(Bloomberg) — Stocks set a fresh four-month high in Europe and German equities erased losses for the year after leaders agreed on a landmark recovery plan.
Microsoft Corp., Tesla Inc. and Apple Inc. advanced in U.S. pre-market trading. S&P 500 Index equity futures pointed to more gains on Tuesday after a blistering rally that sent the Nasdaq 100 Index to its best gain in almost three months.
Markets across Europe have given a vote of confidence to the 750 billion-euro ($860 billion) stimulus package that also tightens the region’s financial ties. A gauge of risk in Europe’s investment-grade debt dropped to the lowest since February. The dollar fell with Treasuries. Silver extended its rally toward $21 an ounce.
Stocks are marching higher globally on the back of more government stimulus and a seemingly unstoppable advance in technology companies that benefit from online shopping during the pandemic.
The tech-heavy gauge is
(Bloomberg) — European stocks climbed to a four-month high and German equities erased losses for the year after leaders agreed on a landmark recovery plan.
Markets across the region are giving a vote of confidence to the 750 billion euros ($860 billion) stimulus package. Italy’s stock benchmark added 2%, leading gains among local exchanges. A gauge of risk in Europe’s investment-grade debt dropped to the lowest since February. The euro steadied after a recent rally.
Norway’s Adevinta ASA surged 29% after agreeing to buy EBay Inc.’s online classifieds business for $9.2 billion, ending one of the largest auctions of the year. Silver extended gains above $20 an ounce.
Stocks globally are marching higher on the back of more government stimulus and an unstoppable advance in technology companies that benefit from people shopping more online due to the pandemic. U.S. equity futures pointed to more gains on Tuesday after a blistering
It’s that time of year again. Earnings season is in full swing, and investors are bracing for some bad news as companies report their second quarter results. Ahead of the upcoming prints, the Street is calling for a sharp profit decline as a result of the COVID-19 pandemic and the heavy blow it dealt to the economy.
While the results could be rough for many, the pros from RBC Capital argue that the health crisis has altered consumer behavior for the foreseeable future. To this end, the investment firm, which lands within the top four on TipRanks’ list of Top Performing Research Firms, reevaluated several large-cap names in its coverage universe before their earnings releases, locking in on two FAANG stocks poised to emerge from the crisis as winners.
Using TipRanks’ database, we pulled up the details on these two stocks to find out how the rest of the Street
As equity markets continue to recover after the collapse earlier in the year, many shares are now overvalued, according to Morningstar analysts.
Investors looking to capitalise on lockdown trends have chased e-commerce, tech and healthcare stocks, driving valuations ever higher. Indeed, Tesla’s (TSLA) shares have soared 200% this year, for example, while Shopify (SHOP) is up nearly 140%. Such a rapid upward trajectory may not be a signal to buy, however – analysts warn many of these hot stocks are looking expensive.
UK Stocks to Avoid
We last looked stocks to avoid in April when valuations were starting to move higher after March’s sell-off.
To compile this list we look at stocks with an Uncertainty Rating of High or Very High, which have no Economic Moat, and which are rated as either one or two stars by Morningstar analysts, indicating that their shares are trading above their fair